National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
NCI Drug Dictionary
Page Options
Print This Page  Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
Contains
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

fluorouracil  Patient Information
An antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity. Fluorouracil and its metabolites possess a number of different mechanisms of action. In vivo, fluoruracil is converted to the active metabolite 5-fluoroxyuridine monophosphate (F-UMP); replacing uracil, F-UMP incorporates into RNA and inhibits RNA processing, thereby inhibiting cell growth. Another active metabolite, 5-5-fluoro-2'-deoxyuridine-5'-O-monophosphate (F-dUMP), inhibits thymidylate synthase, resulting in the depletion of thymidine triphosphate (TTP), one of the four nucleotide triphosphates used in the in vivo synthesis of DNA. Other fluorouracil metabolites incorporate into both RNA and DNA; incorporation into RNA results in major effects on both RNA processing and functions. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonyms:5-fluorouracil
5-Fluracil
Fluoro Uracil
Fluouracil
FU
US brand names:Adrucil
Efudex
Fluoroplex
Foreign brand names:AccuSite
Actino-Hermal
Arumel
Cytosafe
Efurix
Fiverocil
Flurablastin
Fluracedyl
Fluracil
Fluril
Fluroblastin
Flurox
Ribofluor
Timazin
Abbreviation:5-FU
Code name:Ro-2-9757
Chemical structure names:
  • 2,4-Dioxo-5-fluoropyrimidine
  • 5-Fluoro-2,4(1H,3H)-pyrimidinedione


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov